Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $4.8 million.

  • Ironwood Pharmaceuticals' Other Non-Current Assets fell 2292.76% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 2292.76%. This contributed to the annual value of $5.9 million for FY2024, which is 6416.3% up from last year.
  • According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Other Non-Current Assets is $4.8 million, which was down 2292.76% from $5.2 million recorded in Q2 2025.
  • Ironwood Pharmaceuticals' Other Non-Current Assets' 5-year high stood at $6.3 million during Q3 2024, with a 5-year trough of $820000.0 in Q1 2023.
  • In the last 5 years, Ironwood Pharmaceuticals' Other Non-Current Assets had a median value of $3.4 million in 2024 and averaged $2.9 million.
  • In the last 5 years, Ironwood Pharmaceuticals' Other Non-Current Assets skyrocketed by 34954.13% in 2023 and then crashed by 2292.76% in 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Other Non-Current Assets (Quarter) stood at $1.0 million in 2021, then fell by 15.3% to $847000.0 in 2022, then soared by 325.97% to $3.6 million in 2023, then soared by 64.16% to $5.9 million in 2024, then dropped by 18.22% to $4.8 million in 2025.
  • Its Other Non-Current Assets stands at $4.8 million for Q3 2025, versus $5.2 million for Q2 2025 and $5.5 million for Q1 2025.